Beh�et's disease with gastrointestinal involvement associated with myelodysplasia in a patient with congenital panhypopituitarism-Reference-Cited by-同舟云学术

Beh�et's disease with gastrointestinal involvement associated with myelodysplasia in a patient with congenital panhypopituitarism

Published:1998-11 Issue:6 Volume:17 Page:515-517
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Rossa A. Della,Tavoni A.,Tognetti A.,Testi C.,Bombardieri S.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/BF01451290.pdf

Reference12 articles.

1. Snyderman R. Musculoskeletal and connective tissue diseases. In: Wyngaarden S, editor. Beh�et's disease: Cecil textbook of medicine. Philadelphia: WB Saunders, 1985:160?2.

2. International Study Group for Beh�et's Disease. Criteria for the diagnosis of Beh�et's disease. Lancet 1990;335:1078?80.

3. Ketch LL, Buerk CA, Liechty RD. Surgical implication of Beh�et's disease. Arch Surg 1980;115:759?60.

4. Sakate K, Yada K, Ikehara T, et al. Pyloric stenosis: an unusual complication of Beh�et's disease. Am J Gastroenterol 1986; 81:816?8.

5. Lee RG. The colitis of Beh�et's syndrome. Am J Surg Pathol 1986;10:888?92.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune disorders associated with myelodysplastic syndromes: clinical, prognostic and therapeutic implications;Leukemia Research;2022-06

2. Syndrome de pseudo-Behçet et autres manifestations dysimmunitaires associées aux syndromes myélodysplasiques avec trisomie 8;La Revue de Médecine Interne;2021-03

3. How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review;Annals of Hematology;2020-03-05

4. Gastrointestinal Behcet’s-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review;Leukemia & Lymphoma;2018-11-20

5. The burden of autoimmunity in myelodysplastic syndromes;Hematological Oncology;2017-04-27